![Milos Miljkovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Milos Miljkovic
Plus aucun poste en cours
Fortune : 87 882 $ au 30/06/2026
Profil
Milos Miljkovic served as Chief Medical Officer at Cartesian Therapeutics, Inc. (United States) from 2021 to 2023.
Dr. Miljkovic also served as Chief Medical Officer at Cartesian Therapeutics, Inc. from 2023 to 2026.
Former job(s) include Chief Medical Officer at Cartesian Therapeutics, Inc. (United States) and Cartesian Therapeutics, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,03 % | 14/04/2026 | 8 434 ( 0,03 % ) | 87 882 $ | 30/06/2026 |
Anciens postes connus de Milos Miljkovic
| Sociétés | Poste | Fin |
|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Directeur Technique/Scientifique/R&D | 13/11/2023 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Commercial Services |
